Skip to content

Autogenous Sticky Bone Plus Platelet-rich Fibrin Membrane Versus Xenograft With Collagen Membrane for Posterior Atrophic Mandible

Autogenous Sticky Bone Plus Platelet-rich Fibrin Membrane Versus Xenograft With Collagen Membrane for Treatment of Posterior Atrophic Mandible (A Randomized Controlled Clinical Trial)

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07825896
Enrollment
26
Registered
2026-09-17
Start date
2026-09-25
Completion date
2027-06-30
Last updated
2026-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ridge Augmentation

Brief summary

Background: Teeth loss in the posterior mandible initiates residual ridge resorption, this causes difficulty in implant placement so ridge augmentation must be done either simultaneous with implant placement or in a staged approach Aim: To evaluate the effect of autogenous sticky bone with PRF membrane and xenograft with collagen membrane with simultaneous implant placement clinically on primary and secondary implant stability, and radiographically on bucco-lingual width gain, bone density and crestal bone loss

Interventions

OTHERautogenous sticky bone + PRF membrane

Patients in this group will be treated using autogenous sticky bone with PRF membrane.

OTHERXenograft + collagen membrane

Patients in this group will be treated using a xenograft with a collagen membrane.

Sponsors

Alexandria University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Patients with missing posterior mandibular teeth. * Horizontal bone defect with width \< 5.5 mm. * Adequate zone of keratinized tissue

Exclusion criteria

* Presence of infection or periapical lesions in adjacent teeth. * Medically compromised patients with a condition that affects the procedure. * Insufficient inter-arch distance. * Bruxism or clenching. * Alcoholism. * Heavy Smokers.

Design outcomes

Primary

MeasureTime frameDescription
Change in implant stabilityup to 6 monthsImplant stability will be recorded immediately after placement (1ry stability) and after 6 months (2ry stability ) by using osstell device. The result is presented in form of ISQ value from 1 to 100, the higher the ISQ the higher the stability of implant
change in bucco-lingual bone thicknessup to 6 monthsAll participants in the study will be advised to undergo CBCT before implant placement to measure bucco-lingual bone thickness, and again 7 days postoperatively and 6 months after implant placement to assess the following.
change in marginal bone levelup to 9 monthsAt buccal, lingual, mesial, and distal sites will be evaluated radiographically from the shoulder of the implant to the alveolar crest. The mean marginal bone loss after the placement of implants will be calculated by subtracting baseline value from the values obtained at 6 and 9 months post implant placement
change in ridge widthup to 6 monthsWill be measured immediately and after 6 months, bone width will be measured for each implant at three levels (2, 5, and 10 mm from the alveolar crest) and the mean will be calculated for each implant at each time interval.

Secondary

MeasureTime frameDescription
change in pain scoresup to 7 daysPain will be assessed for 7 days postoperatively using 10-point visual analouge scale (VAS). (0-1=None, 2-4=mild, 5-7=moderate, 8-10=severe ).
change in edema scoresup to 7 daysEdema will be assessed by a descriptive 4-point scale immediately post-operative, and at the 2nd,3rd,7th days postoperatively. Measured as follows: No inflammation = none. Intra oral swelling confined to the surgical field = mild. Extra oral swelling in the surgical zone =moderate. Extra oral swelling spreading beyond the surgical zone =intense.
change in bone densityup to 6 monthsWill be measured at 6 points around the implant and a mean value will be calculated

Countries

Egypt

Contacts

CONTACTMohamed Essam, BDS
mohamedessam2363@gmail.com01225710437

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 18, 2026